Test Code LIVPR Liver Profile, Serum
Reporting Name
Hepatic Function Panel, SPerforming Laboratory
Mayo Clinic Laboratories in RochesterUseful For
Screening for liver damage, especially if someone has a condition or is taking a drug that may affect the liver
Method Name
BILIT: Photometric, Diazonium Salt
BILID: Photometric, Diazotized Sulfanilic Acid
AST: Photometric Rate, L-Aspartate with Pyridoxyl-5-Phosphate
ALT: Photometric Rate, L-Alanine with Pyridoxal-5-Phosphate
ALP: Photometric, p-Nitrophenol Phosphate
ALB: Photometric, Bromcresol Green
TP: Colorimetric, Biuret
Shipping Instructions
Ship specimen in amber vial to protect from light.
Necessary Information
Patient's age and sex are required.
Specimen Required
Supplies: Amber Frosted Tube, 5 mL (T915)
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Amber vial
Specimen Volume: 0.6 mL
Collection Instructions:
1. Serum gel tubes should be centrifuged within 2 hours of collection.
2. Red-top tubes should be centrifuged, and the serum aliquoted into an amber vial within 2 hours of collection.
Specimen Type
SerumSpecimen Minimum Volume
0.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated | 7 days |
Reject Due To
Gross hemolysis | Reject |
Gross lipemia | OK |
Reference Values
TOTAL BILIRUBIN
0-6 days: Refer to http://bilitool.org/ for information on age-specific (postnatal hour of life) serum bilirubin values.
7-14 days: 0.0-14.9
15 days to 17 years: 0.0 -1.0
>18 years: 0.0-1.2
DIRECT BILIRUBIN
≥12 months: 0.0-0.3 mg/dL
Reference values have not been established for patients who are younger than 12 months of age.
ASPARTATE AMINOTRANSFERASE
Males
0-11 months: Not established
1-13 years: 8-60 U/L
≥14 years: 8-48 U/L
Females
0-11 months: Not established
1-13 years: 8-50 U/L
≥14 years: 8-43 U/L
ALANINE AMINOTRANSFERAASE
Males
≥1 year: 7-55 U/L
Reference values have not been established for patients who are younger than 12 months of age.
Females
≥1 year: 7-45 U/L
Reference values have not been established for patients who are younger than 12 months of age.
ALKALINE PHOSPHATASE
Males
4 years: 149-369 U/L
5 years: 179-416 U/L
6 years: 179-417 U/L
7 years: 172-405 U/L
8 years: 169-401 U/L
9 years: 175-411 U/L
10 years: 191-435 U/L
11 years: 185-507 U/L
12 years: 185-562 U/L
13 years: 182-587 U/L
14 years: 166-571 U/L
15 years: 138-511 U/L
16 years: 102-417 U/L
17 years: 69-311 U/L
18 years: 52-222 U/L
≥19 years: 45-115 U/L
Females
4 years: 169-372 U/L
5 years: 162-355 U/L
6 years: 169-370 U/L
7 years: 183-402 U/L
8 years: 199-440 U/L
9 years: 212-468 U/L
10 years: 215-476 U/L
11 years: 178-526 U/L
12 years: 133-485 U/L
13 years: 120-449 U/L
14 years: 153-362 U/L
15 years: 75-274 U/L
16 years: 61-264 U/L
17-23 years: 52-144 U/L
24-45 years: 37-98 U/L
46-50 years: 39-100 U/L
51-55 years: 41-108 U/L
56-60 years: 46-118 U/L
61-65 years: 50-130 U/L
≥66 years: 55-142 U/L
Reference values have not been established for patients who are younger than 4 years of age.
ALBUMIN
≥12 months: 3.5-5.0 g/dL
Reference values have not been established for patients who are younger than 12 months of age.
TOTAL PROTEIN
≥1 year: 6.3-7.9 g/dL
Reference values have not been established for patients who are younger than 12 months of age.
Interpretation
Hepatic function panel results are not diagnostic of a specific condition; they indicate that there may be a problem with the liver. In a person who does not have symptoms or identifiable risk factors, abnormal liver test results may indicate a temporary liver injury or reflect something that is happening elsewhere in the body, such as in the skeletal muscles, pancreas, or heart. It may also indicate early liver disease and the need for further testing and periodic monitoring.
Results of liver panels are usually evaluated together. Several sets of results from tests performed over a few days or weeks are often assessed together to determine if a pattern is present. Each person will have a unique set of test results that will typically change over time. A healthcare practitioner evaluates the combination of liver test results to gain clues about the underlying condition. Often, additional testing is necessary to determine what is causing the liver damage or disease.
Day(s) Performed
Monday through Sunday
Report Available
Same day/1 to 2 daysTest Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
82247
82248
84450
84460
84075
82040
84155
80076 (if appropriate if all analytes performed)
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
LIVPR | Hepatic Function Panel, S | 24325-3 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
BILIT | Bilirubin Total, S | 1975-2 |
BILID | Bilirubin, Direct | 1968-7 |
AST | Aspartate Aminotransferase (AST), S | 30239-8 |
ALT | Alanine Aminotransferase (ALT), S | 1743-4 |
ALP | Alkaline Phosphatase, S | 6768-6 |
ALB | Albumin, S | 1751-7 |
TP | Protein, Total, S | 2885-2 |